Next Article in Journal
Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study
Next Article in Special Issue
Probiotics as Adjuvants in Vaccine Strategy: Is There More Room for Improvement?
Previous Article in Journal
Knowledge, Vaccination Status, and Reasons for Avoiding Vaccinations against Hepatitis B in Developing Countries: A Systematic Review
Previous Article in Special Issue
SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center
 
 
Review

Article Versions Notes

Vaccines 2021, 9(6), 626; https://doi.org/10.3390/vaccines9060626
Action Date Notes Link
article pdf uploaded. 9 June 2021 17:28 CEST Version of Record https://www.mdpi.com/2076-393X/9/6/626/pdf-vor
article xml file uploaded 10 June 2021 09:46 CEST Original file -
article xml uploaded. 10 June 2021 09:46 CEST Update https://www.mdpi.com/2076-393X/9/6/626/xml
article pdf uploaded. 10 June 2021 09:46 CEST Updated version of record https://www.mdpi.com/2076-393X/9/6/626/pdf
article html file updated 10 June 2021 09:47 CEST Original file -
article html file updated 26 July 2022 23:38 CEST Update https://www.mdpi.com/2076-393X/9/6/626/html
Back to TopTop